Readystate Asset Management LP Merck & Co., Inc. Call Options Transaction History

Readystate Asset Management LP

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$111.15 - $128.97 $10.3 Million - $12 Million	92,700 Added 702.27%	105,900 $12 Billion
Q2 2024 Aug 14, 2024	SELL	$123.8 - $132.96 $13.3 Million - $14.3 Million	-107,300 Reduced 89.05%	13,200 $1.63 Billion
Q1 2024 May 10, 2024	BUY	$113.24 - $131.95 $13.3 Million - $15.5 Million	117,800 Added 4362.96%	120,500 $15.9 Billion
Q4 2023 Feb 14, 2024	BUY	$100.18 - $109.02 $270,486 - $294,354	2,700 New	2,700 $294 Million
Q1 2023 May 15, 2023	BUY	$102.94 - $114.86 $288,232 - $321,608	2,800 New	2,800 $298 Million

3,827

1.87B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Readystate Asset Management LP, based on Form 13F filings with the SEC.

Stay updated on Readystate Asset Management LP with notifications on news.